−228
Iovance Biotherapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−293
FY23:
−362
FY24:
−353
FY25:
−302
Change from FY21 to FY25
millions USD
FY21:
0.13
FY22:
256
FY23:
−155
FY24:
−96.4
FY25:
47.5
Change from FY21 to FY25
millions USD
FY21:
239
FY22:
190
FY23:
463
FY24:
391
FY25:
301
millions USD
FY21:
11.5
FY22:
154
FY23:
−56.8
FY24:
−59.3
FY25:
47.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−266
FY22:
−313
FY23:
−384
FY24:
−364
FY25:
−336
All amounts in millions USD